FIELD: medicine.
SUBSTANCE: invention refers to a method for obtaining the information describing a physical-chemical parameter by the magnetic-resonant tomography (MRT) after a contrast medium is introduced to a patient. Said contrast medium contains a resistant contrast-increasing component giving a first signal with a contrast-increasing ability which is independent of the physical-chemical parameter to be determined, and an unaffected contrast-increasing component giving a second signal different from the first one with the contrast-increasing ability which depends on the physical-chemical parameter to be determined. The declared method involves MRT imaging of a patient's body, calibration imaging by recording of the first signal from the resistant contrast-increasing component, and measuring of the physical-chemical parameter by the MRT images and the calibration images with the calibration images being used in order to adjust the physical-chemical parameter to calculate the involvement of the contrast agent concentration in the MRT imaging. Besides, the invention refers to a data medium which stores a machine readable software wherein the method stated above is implemented on a computer. The invention also refers to a MRT system comprising a MRT imaging means, a calibration imaging means, and a means for measuring the physical-chemical parameter, as well as to an intravenous preparation containing the contrast agent specified above.
EFFECT: invention provides the decreased or eliminated involvement of the contrast agent involvement in the MRT imaging.
29 cl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
DRUG CARRIER FOR CONTRAST ENHANCEMENT IN MRT | 2009 |
|
RU2528104C2 |
CEST SYSTEMS PROVIDING SENSITIVITY NOT DEPENDING ON CONCENTRATION | 2011 |
|
RU2605823C2 |
LIPID BILAYER CARRIER FOR MEDICINAL AND IMAGING AGENTS | 2011 |
|
RU2577291C2 |
POLYMER CARRIER OF DRUG PREPARATIONS FOR VISUALLY-ASSISSTED DELIVERY | 2008 |
|
RU2477146C2 |
APPLICATION OF 1,3-BIS(PERFLUORO-TERT-BUTYL)PROPANE AS A CONTRAST AGENT FOR MAGNETIC RESONANCE IMAGING ON F NUCLEI | 2022 |
|
RU2785791C1 |
CHELATE AMPHIPHILIC POLYMERS | 2009 |
|
RU2519713C2 |
MAGNETIC RESONANCE (MR) | 2013 |
|
RU2605516C2 |
METHOD FOR ASSESSING QUANTITATIVE ACCUMULATION OF A PARAMAGNETIC CONTRAST PREPARATION GDOF-Mn-DTPA FOR MAGNETIC RESONANCE IMAGING OF EXPERIMENTAL ANIMALS | 2018 |
|
RU2699334C1 |
1,2-BIS(PERFLUORO-tert-BUTOXY)ETHANE AS A CONTRAST FOR F NUCLEUS MAGNETIC RESONANCE IMAGING | 2022 |
|
RU2795915C1 |
DIAGNOSTIC TECHNIQUE FOR GLIOBLASTOMA MULTIFORME BY MAGNETIC RESONANCE TOMOGRAPHY | 2012 |
|
RU2530762C2 |
Authors
Dates
2012-04-10—Published
2007-06-08—Filed